Amid the deadly chaos caused due to the Coronavirus, vaccines emerged as a boon for humanity. These vaccines have been produced at lightning speed. The leading vaccine manufacturers have been leading the vaccine industry, such as United States biotechnology company Moderna and German pharmaceutical company Pfizer. Further, the vaccines produced by these companies have been proven to be 95% effective in reducing the mortality rate due to Coronavirus. As the vaccines produced by these companies are in high demand, developed nations like the United States of America and the United Kingdom have granted indemnity to these companies from civil liability. In India, there are no such legal arrangements for vaccine manufacturers to escape criminal or civil liability. Thus, the purpose of this paper is to examine the viability of indemnity contracts with the vaccine manufacturers in India, considering that a similar demand for indemnity clause has been made by the Serum Institute of India, which has been producing vaccines for Coronavirus on a large scale in India.
